Thomas Charles Rogers

2018Annual

Ask Donna

Pull out the substance of this filing.

What was filed

  • 94

    investments

  • 0

    positions

  • 0

    gifts

  • 0

    agreements

  • 0

    debts

  • 0

    reimbursements

  • 0

    income

  • 0

    spouse income

As filed

1.25a Florence C (1/2011. $10,000) — None

Brokerage account # (Marked as # )

First Clearing, LLC - Cash balance — None

1-AT&T Inc — Int/Div

1 - Synergy Pharmaceuticals Inc. (SGYP) — None

6. — None

4] «Verizon Communications Com — Int/Div

1-SC Jobs Econ DV Ath Stdnt 4.25% R124 "Y" — Interest

1 «General Electric Company — Int/Div — Buy

1 «General Electric Company — Sold

Brokerage account # 2 (Marked as # 2)

2. Cash balance - First Clearing, LLC — Int/Div

2. Exxon Mobil Corp — Int/Div

Brokerage account # 3 (Marked as # 3)

3. Ameritrade MMDA Account - Cash balance — Ine

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Int/Div — Sold (part)

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Buy

3. Synergy Pharmaceuticals Inc Com (SGYP™) — Sold (part)

43 AT&T Inc (T) — Int/Div — Buy

43 AT&T Inc (T) — Sold

S10. — Buy

S10. — Sold

43 Arotech Corporation Com (ARTX) — None — Buy

43 Arotech Corporation Com (ARTX) — Sold

3. General Electric Co Com (GE) — Int/Div — Buy

3. General Electric Co Com (GE) — Sold

3- Quicklogic corp Com (QUIK) — None — Buy

3- Quicklogic corp Com (QUIK) — Sold

3- Quicklogic corp Com (QUIK) — Buy

3- Quicklogic corp Com (QUIK) — Sold

3- Quicklogic corp Com (QUIK) — Buy

3- Quicklogic corp Com (QUIK) — Sold

3. Snap Inc Com Cl A (SNAP) — None — Buy

3. Snap Inc Com Cl A (SNAP) — Sold

South State Bank checking — None

Synovus (Formerly NBSC) — Interest

Wells Fargo, NA — Interest

Equitable Variable: EQ Aggressive (whole life policy) — None

Jefferson-Pilot Adjustable Life policy — None

UGMA 2 A (Markedas 2 A)

A - Capital World Growth & Income Fund « Class F-1 (CWGFX) — Int/Div

2A - First Clearing , LLC - Cash balance — Interest

A American Fds Washington Mut (Edu Svgs Acct)no control) — Int/Div

UGMA £ A. Trust (Marked as 2 ATI)

ATI - First Clearing, LLC - Cash balance — Int/Div

2ATI-AT&T Inc. (T) — Int/Div

2 ATI - Hartford Fortis Funds (HGOCX) — Int/Div — Sold (part)

2 ATI - Hartford Fortis Funds (HGOCX) — Sold (part)

2 ATI - Hartford Mut Fds Inc (HIOCX) — Int/Div — Sold (part)

2 ATI - Hartford Mut Fds Inc (HIOCX) — Sold (part)

2 ATI - Hartford Mut Fds Inc (HIOCX) — Sold (part)

2 ATI - Hartford Mut Fds Inc (HIOCX) — Sold (part)

2 ATI - Hartford Mut Fds Inc (HIOCX) — Sold

2 ATI - Hartford Mut Fds (HDGCX) — Int/Div — Sold (part)

2 ATI -MFS Ser Tr XH (DIFCX) — Int/Div

2 ATI - Principal Fds Inc (PMSCX) — Int/Div — Sold (part)

2 ATI - Principal Fds Inc (PMSCX) — Sold (part)

2 ATI - Principal Fds Inc (PMSCX) — Sold

2 ATI - Thorburg Invt Tr {THOCX) — Int/Div — Sold (part)

2 ATI - Thorburg Invt Tr {THOCX) — Sold (part)

2 ATI - Thorburg Invt Tr {THOCX) — Sold

UGMA # B (Marked ad # B)

4B - Capital World Growth & Income Fund «FL ICWGFX) — Int/Div

2B First Clearing , LLC - Cash balance — Interest

B Columbia Mgmt Futre Schol 529 Collge Swng Pl (no control) — Int/Div

In Part VIL, page 4. line 1, Column B(1) for 1.25 acres Florence County received no rental income for the year therefore, column B{2) is "None".

Part VII Investments and Trust, line 70 and 92 Capital World Growth & Income Fd Ine C1 C (CWGCX) converts to Class F-1 shares after 10 years, The exchange

took place on 12/13/2016. The converted shares are called Capital World Growth & Income Fund-Class F-1 (CWCFX),

Part VII, lines 3, 12, 15, 71,74, and 93 are the money market account portions of the brokerage accounts which act as sweep accounts for uninvested cash mn that

specific brokerage account. We believe these to be a widely held accounts because they are a part of the brokerage accounts.

Part VII, lines 2, 11, 14, 69, 73, and 91 are header lines for the investments listed below the specific line.

Part VII, lines 5 and 6, Synergy Pharmaceuticals, Inc (SGYP) was purchased twice on 08/11/2017. Both of these transactions were erroneously omitted from the

prior years schedule. Both purchases combined amount to less than $15,000.00 total.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.

Thomas Charles Rogers | Frix